Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tokuyama Corporation (4043.T)
Tokyo, JP
Tokuyama Corporation produces and sells various chemical products in Japan. It operates through Chemicals, Cement, Advanced Electronic Materials, Life Science, Environmental Business, and Others segments. The Chemicals segment offers caustic soda, soda ash, calcium chloride, sodium silicate cullet, sodium bicarbonate, purifeed, vinyl chloride monomer, polyvinyl chloride resin, propylene oxide, methylene chloride, polyrotaxanes, and chloroform. Its Cement segment provides cement, ready-mixed concrete as well as engages in the recycling and environment business. The Advanced Electronic Materials segment provides polycrystalline silicon; fumed silica and tetrachlorosilane; aluminum nitride; high-purity chemicals for electronics manufacturing and photoresist developer; and isopropyl alcohol. Its Life Science segment provides medical diagnosis systems, dental materials and photochromic materials, advanced pharmaceutical ingredients and intermediates, health foods, plastic lens-related materials for glasses, and microporous film. The Environment Business segment offers plastic window sashes, ion exchange membranes, as well as engages in waste gypsum board recycling activity. The company was formerly known as Tokuyama Soda Co., Ltd. and changed its name to Tokuyama Corporation in April 1994. Tokuyama Corporation was incorporated in 1918 and is headquartered in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +7.90% | +12.41% | +27.74% | +14.10% | +24.38% | +22.53% | +81.04% | +129.84% | +122.62% | +249.79% | +126.98% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | -1 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+1.9% Q1'26: +9.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-5.1% Q1'26: -48.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+7.0% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+10.6% ★ Q1'26: +10.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+5.5% Q1'26: +6.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.80× Q1'26: 2.66× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 3 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 3 Rev. Ana. 3 EPS Ana. |
Mar 2029 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
302.09B
est: 304.70B (-0.9%)
|
307.12B
est: 302.03B (+1.7%)
|
299.11B
est: 287.50B (+4.0%)
|
308.06B
est: 306.80B (+0.4%)
|
324.66B
est: 322.40B (+0.7%)
|
316.10B
est: 322.08B (-1.9%)
|
302.41B
est: 297.30B (+1.7%)
|
293.83B
est: 293.40B (+0.1%)
|
351.79B
est: 357.00B (-1.5%)
|
341.99B
est: 339.63B (+0.7%)
|
343.07B
est: 347.06B (-1.1%)
|
353.20B
350.94B – 357.23B
+1.8% YoY
|
376.48B
372.31B – 383.52B
+6.6% YoY
|
393.58B
385.05B – 408.00B
+4.5% YoY
|
335.00B
331.30B – 341.27B
-14.9% YoY
|
| EBITDA |
39.59B
est: 43.67B (-9.4%)
|
44.53B
est: 43.29B (+2.9%)
|
55.19B
est: 41.21B (+33.9%)
|
56.54B
est: 43.97B (+28.6%)
|
51.30B
est: 46.21B (+11.0%)
|
50.61B
est: 46.17B (+9.6%)
|
47.94B
est: 42.61B (+12.5%)
|
44.28B
est: 42.05B (+5.3%)
|
35.39B
est: 51.17B (-30.8%)
|
43.41B
est: 68.34B (-36.5%)
|
49.72B
est: 69.84B (-28.8%)
|
71.07B
70.62B – 71.88B
+1.8% YoY
|
75.75B
74.92B – 77.17B
+6.6% YoY
|
79.20B
77.48B – 82.10B
+4.5% YoY
|
67.41B
66.66B – 68.67B
-14.9% YoY
|
| EBIT |
19.53B
est: 25.91B (-24.6%)
|
23.07B
est: 25.68B (-10.2%)
|
39.72B
est: 24.45B (+62.5%)
|
41.27B
est: 26.09B (+58.2%)
|
35.26B
est: 27.42B (+28.6%)
|
33.30B
est: 27.39B (+21.6%)
|
30.17B
est: 25.28B (+19.3%)
|
23.98B
est: 24.95B (-3.9%)
|
14.34B
est: 30.36B (-52.8%)
|
25.64B
est: 51.28B (-50.0%)
|
29.97B
est: 52.40B (-42.8%)
|
53.33B
52.99B – 53.94B
+1.8% YoY
|
56.84B
56.22B – 57.91B
+6.6% YoY
|
59.43B
58.14B – 61.60B
+4.5% YoY
|
50.58B
50.02B – 51.53B
-14.9% YoY
|
| Net Income |
-65.35B
est: -77.56B (+15.7%)
|
-100.56B
est: -109.06B (+7.8%)
|
52.17B
est: 25.54B (+104.2%)
|
19.70B
est: 15.73B (+25.2%)
|
34.28B
est: 26.98B (+27.1%)
|
19.94B
est: 26.82B (-25.7%)
|
24.54B
est: 26.21B (-6.4%)
|
28.00B
est: 19.48B (+43.7%)
|
9.36B
est: 12.29B (-23.8%)
|
17.75B
est: 20.85B (-14.9%)
|
23.39B
est: 24.92B (-6.2%)
|
28.16B
27.02B – 29.30B
+13.0% YoY
|
35.20B
34.52B – 35.88B
+25.0% YoY
|
37.00B
34.13B – 37.08B
+5.1% YoY
|
30.50B
30.06B – 31.24B
-17.6% YoY
|
| SGA |
54.40B
est: 59.15B (-8.0%)
|
55.90B
est: 58.63B (-4.7%)
|
50.57B
est: 55.81B (-9.4%)
|
52.27B
est: 59.56B (-12.2%)
|
55.62B
est: 62.59B (-11.1%)
|
56.21B
est: 62.53B (-10.1%)
|
54.63B
est: 57.71B (-5.3%)
|
59.49B
est: 56.96B (+4.5%)
|
64.09B
est: 69.30B (-7.5%)
|
60.69B
est: 67.86B (-10.6%)
|
63.55B
est: 69.34B (-8.4%)
|
70.57B
70.11B – 71.37B
+1.8% YoY
|
75.22B
74.39B – 76.62B
+6.6% YoY
|
78.63B
76.93B – 81.52B
+4.5% YoY
|
66.93B
66.19B – 68.18B
-14.9% YoY
|
| EPS |
-939.25
est: -1,078.00 (+12.9%)
|
-1,445.50
est: -1,515.75 (+4.6%)
|
738.90
est: 355.00 (+108.1%)
|
259.80
est: 218.60 (+18.8%)
|
493.26
est: 374.96 (+31.5%)
|
287.05
est: 372.72 (-23.0%)
|
351.10
est: 364.33 (-3.6%)
|
389.09
est: 270.76 (+43.7%)
|
130.14
est: 171.88 (-24.3%)
|
246.71
est: 289.77 (-14.9%)
|
325.08
est: 344.67 (-5.7%)
|
390.22
375.53 – 407.21
+13.2% YoY
|
486.82
479.82 – 498.66
+24.8% YoY
|
488.92
474.38 – 515.36
+0.4% YoY
|
423.90
417.81 – 434.21
-13.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-25 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | MUFG Japan Small Cap Active ETF MJSC | 1.19% | 271.8K | 0.85% |
| 2 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.36% | 1.36M | 0.58% |
| 3 | iShares International Developed Small Cap Value Factor ETF ISVL | 0.28% | 892.6K | 0.31% |
| 4 | Avantis International Small Cap Value ETF AVDV | 0.22% | 41.24M | 0.36% |
| 5 | Schwab Fundamental International Small Company Index ETF FNDC | 0.14% | 4.14M | 0.39% |
| 6 | WisdomTree International SmallCap Dividend Fund DLS | 0.13% | 1.40M | 0.58% |
| 7 | iShares MSCI Japan Small-Cap ETF SCJ | 0.13% | 346.5K | 0.50% |
| 8 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.13% | 566.0K | 0.48% |
| 9 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.13% | 743.3K | 0.58% |
| 10 | FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund TLTD | 0.11% | 741.8K | 0.41% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akihiro Hamada | Adviser | — | male |
| Etsuji Uchida | Executive Officer & Director of Engineering Center | — | — |
| Fumiaki Iwasaki | Senior Managing Executive Officer & Director | — | male |
| Hiroshi Fujimoto | Executive Officer and Head of Purchasing & Logistics Department | — | — |
| Hiroshi Yokota | Executive Officer, Representative Director & Chairman | — | male |
| Hirotaka Nishihara | Managing Executive Officer & President of Tokuyama Dental Corporation | — | — |
| Katsumi Nagase | Manag Exe Off, GM of Elec & Adv Materials Biz HQ, Ad Materials Biz Div. | — | — |
| Kenji Saka | Executive Officer & GM of Digital Headquarters and Leader of DX Promotion Group | — | — |
| Masao Kusunoki | Corporate Advisor | — | male |
| Michiko Seki | Executive Officer and Head of CSR Promotion Division & Sustainability Headquarters | — | — |
| Nagatomo Kashiwabara | General Manager of Fin., Fin. & Investment and Financing Group & Corp. Planning Div. | — | — |
| Naoki Tamura | Executive Officer & Head of Environmental Business Division | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4043.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
